Targeted therapy promising for HER2-positive metastatic breast cancer
Friday, October 8, 2010 - 13:00
in Health & Medicine
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.